eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatitis c |
| Symptom | C0239946|liver fibrosis |
| Sentences | 93 |
| PubMedID- 25970201 | However, the diagnostic accuracy of pswe and te was comparable for the noninvasive staging of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 26450804 | Ultimately, sustained virological response to hepatitis c therapy is associated with liver fibrosis regression in patients with hiv/hcv coinfection. |
| PubMedID- 23112543 | Liver biopsy (lb) has traditionally been considered the gold standard for pretreatment evaluation of liver fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 22138940 | The limitations of and the invasive nature of liver biopsy has spurred extensive interest in the development of non-invasive tests to measure liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23301544 | Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22412904 | Subsequent reports showed that the presence of k8/k18 variants predisposes to liver fibrosis development in patients with chronic hepatitis c and primary biliary fibrosis as well as to adverse outcome of acute liver failure , 7. |
| PubMedID- 25126010 | Objectives: the aim of the study was to investigate the effect of the therapy with peginterferon alfa-2a or alfa-2b plus ribavirin on evolution of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22235211 | Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23082465 | Accurate monitoring of liver fibrosis changes in patients with hepatitis c virus (hcv) infection would be helpful in defining the need to intervene, implement the appropriate response in treatment and to minimize the use of liver biopsy. |
| PubMedID- 22140539 | We have shown that two isoforms of fibronectin reflect the severity of liver fibrosis in patients with chronic hepatitis c raising the possibility that fibronectin itself may play a role in the pathogenesis of fibrosis 9. |
| PubMedID- 24842533 | We proposed to evaluate the association between serum indirect bilirubin levels and liver fibrosis in patients with chronic hepatitis c (chc) genotype 1b. |
| PubMedID- 22761744 | Further, ip-10 assays have also shown promise for liver fibrosis monitoring in patients with chronic hepatitis c viral infection (hcv) . |
| PubMedID- 20356387 | Serum atx activity and plasma lpa level were increased in chronic hepatitis c in association with liver fibrosis . |
| PubMedID- 21150136 | The objective of this study was to examine the relationship between urinary lcn2 levels and mmp-9 activity with respect to the stage of liver fibrosis in patients with chronic hepatitis c (chc), and to assess the utility of urine lcn2 as a non-invasive marker of hepatic fibrosis. |
| PubMedID- 24424890 | Macrophage-related serum biomarkers soluble cd163 (scd163) and soluble mannose receptor (smr) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis c: a pilot study. |
| PubMedID- 22138553 | Objective: to assess the frequency of severe liver toxicity in hiv/hepatitis c (hcv)-coinfected patients with advanced liver fibrosis receiving efavirenz (efv)-based antiretroviral combinations. |
| PubMedID- 22254137 | Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 20002560 | Transient elastometry (te) could provide a more accurate evaluation of the frequency and risk factors of liver fibrosis in hepatitis c virus (hcv) infection than that based on biopsy. |
| PubMedID- 23245820 | Factors which influence the accuracy of acoustic radiation force impulse (arfi) elastography for the diagnosis of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23626613 | The association of non-o blood group and severity of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 22734850 | Course of liver fibrosis in hiv-hepatitis c virus-coinfected patients depending on the response to hepatitis c therapy. |
| PubMedID- 21898504 | Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis c: new algorithms are more precise and entirely noninvasive. |
| PubMedID- 25534272 | If left untreated, hepatitis c infection can lead to hepatitis, liver fibrosis, cirrhosis and hepatocellular carcinoma. |
| PubMedID- 20802942 | This study had the objective of independently assessing the relationship between previous hepatitis b infection and liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 24023984 | Serum complement c4a and its relation to liver fibrosis in children with chronic hepatitis c. |
| PubMedID- 22401174 | Progression of chronic hepatitis c leads to liver fibrosis and cirrhosis and is associated with an increased risk to develop hepatocellular carcinoma (hcc) . |
| PubMedID- 24237300 | In conclusion, at 500 iu/day, oral interferon exerted a borderline suppression effect of virological relapse in chronic hepatitis c patients with mild liver fibrosis. |
| PubMedID- 22761838 | Discovery of novel biomarker candidates for liver fibrosis in hepatitis c patients: a preliminary study. |
| PubMedID- 22959098 | Performances of elasto-fibrotest((r)), a combination between fibrotest((r)) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 21971536 | Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 19850017 | Automation of the hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis c from the anrs hc ep 23 fibrostar cohort. |
| PubMedID- 22070853 | Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis c infection. |
| PubMedID- 22497817 | End-stage renal disease and african american race are independent predictors of mild liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 20665624 | Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis c after transplantation. |
| PubMedID- 25545640 | Objective: liver fibrosis has been associated with hepatitis c virus (hcv) genotype and genetic variation near the interleukin 28b (il28b) gene, but the relative contribution is unknown. |
| PubMedID- 20630109 | Novel biomarkers predict liver fibrosis in hepatitis c patients: alpha 2 macroglobulin, vitamin d binding protein and apolipoprotein ai. |
| PubMedID- 22162013 | Diagnostic algorithms for liver fibrosis in hepatitis c: are they ready to avoid liver biopsy. |
| PubMedID- 23298655 | Serum markers of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 20963316 | Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis c on haemodialysis. |
| PubMedID- 24815325 | We investigated whether levels of cytokines and extracellular matrix proteins in serum and biopsy samples can be used to determine actual stage of liver fibrosis in patients with chronic hepatitis c (chc) and in prognosis. |
| PubMedID- 26140381 | Opioid use and risk of liver fibrosis in hiv/hepatitis c virus-coinfected patients in canada. |
| PubMedID- 23142332 | Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 25961575 | These two methods are now recommended for first-line evaluation of liver fibrosis in patients with chronic hepatitis c 6. |
| PubMedID- 24335341 | Furthermore, te may be useful in predicting the severity of liver fibrosis progression due to recurrence of hepatitis c virus infection or other underlying liver diseases after transplantation. |
| PubMedID- 21735832 | Assessment of liver fibrosis in patients with chronic hepatitis c (chc) is essential for determination of prognosis, monitoring of the disease and guiding therapeutic decisions. |
| PubMedID- 25874509 | Background/aim: to date, liver biopsy has been the gold standard used for the assessment of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23845056 | Regulation of tsp-1 with regards to its influence on tgf-β1 activity may be one of the causes of fibrosis, as tgf-β1 positively regulates hcv rna replication which is likely manifested in the liver fibrosis associated with hepatitis c infection . |
| PubMedID- 24946280 | Background & aims: there is little information regarding the extent to which difficult to cure patients with advanced liver fibrosis, due to hepatitis c virus genotype-1 (hcv-1) can successfully and safely be treated with triple therapy with telaprevir (tvr), pegylated interferon alpha (p) and ribavirin (r). |
| PubMedID- 21296375 | Collectively, these observations provide insight into the mechanism of tgf-beta1 activation, which likely manifest in liver fibrosis associated with hepatitis c infection. |
| PubMedID- 25580959 | Utility of real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis c infection without cirrhosis: comparison of liver fibrosis indices. |
Page: 1 2